[go: up one dir, main page]

BRPI1014529A2 - Composições de monoglicerídeo de ácido graxo - Google Patents

Composições de monoglicerídeo de ácido graxo

Info

Publication number
BRPI1014529A2
BRPI1014529A2 BRPI1014529-0A BRPI1014529A BRPI1014529A2 BR PI1014529 A2 BRPI1014529 A2 BR PI1014529A2 BR PI1014529 A BRPI1014529 A BR PI1014529A BR PI1014529 A2 BRPI1014529 A2 BR PI1014529A2
Authority
BR
Brazil
Prior art keywords
fatty acid
acid monoglyceride
monoglyceride compositions
compositions
fatty
Prior art date
Application number
BRPI1014529-0A
Other languages
English (en)
Inventor
Hans Hofland
John Lenn
Barry Hunt
Edward Hsia
Original Assignee
Stiefel Laboratories
Stiefel Res Australia Pty Ltd
Hans Hofland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1014529(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Laboratories, Stiefel Res Australia Pty Ltd, Hans Hofland filed Critical Stiefel Laboratories
Publication of BRPI1014529A2 publication Critical patent/BRPI1014529A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1014529-0A 2009-03-20 2010-03-19 Composições de monoglicerídeo de ácido graxo BRPI1014529A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US21331309P 2009-05-28 2009-05-28
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (1)

Publication Number Publication Date
BRPI1014529A2 true BRPI1014529A2 (pt) 2015-08-25

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014529-0A BRPI1014529A2 (pt) 2009-03-20 2010-03-19 Composições de monoglicerídeo de ácido graxo

Country Status (15)

Country Link
US (2) US20110305646A1 (pt)
EP (1) EP2408299B1 (pt)
JP (1) JP5992324B2 (pt)
KR (1) KR101506369B1 (pt)
CN (1) CN102368904B (pt)
AU (1) AU2010226476B2 (pt)
BR (1) BRPI1014529A2 (pt)
CA (1) CA2756047C (pt)
CL (1) CL2011002302A1 (pt)
EA (1) EA022569B1 (pt)
ES (1) ES2437395T3 (pt)
IL (1) IL214887A (pt)
MX (1) MX2011009781A (pt)
PL (1) PL2408299T3 (pt)
WO (1) WO2010108060A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548998T3 (es) * 2009-05-29 2015-10-22 Palau Pharma, S.A. Composiciones antifúngicas de azol
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
EP3124012A4 (en) * 2014-03-26 2017-09-06 Mandom Corporation Deodorant composition and deodorant agent
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
MX2018015475A (es) * 2016-06-13 2019-07-12 Vyome Therapeutics Ltd Composiciones antifungicas sinérgicas y métodos de las mismas.
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
FI912955L (fi) * 1990-06-25 1991-12-26 Res Found Mental Hygiene Antimikroba fettsyrasammansaettningar.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
WO1999039680A1 (en) * 1998-02-09 1999-08-12 Macrochem Corporation Antifungal nail lacquer and method using same
AU2001243189B2 (en) * 2000-02-16 2005-06-09 Cpex Pharmaceuticals, Inc. Pharmaceutical composition
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
BR0312850B1 (pt) * 2002-07-22 2013-06-04 processo para espessar uma composiÇço condicionadora de cabelo À base de Água e/ou àleo, uso de um copolÍmero, e composiÇço para tratamento pessoal À base de àleo/Água.
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
BRPI0409420A (pt) * 2003-04-18 2006-04-25 Merck Patent Gmbh pigmentos antimicrobianos
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8796332B2 (en) * 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
CN102065851A (zh) * 2008-04-25 2011-05-18 纳米生物公司 治疗真菌、酵母和霉菌感染的纳米乳剂

Also Published As

Publication number Publication date
US20110305646A1 (en) 2011-12-15
US20180360791A1 (en) 2018-12-20
JP2012521351A (ja) 2012-09-13
EP2408299B1 (en) 2013-10-23
CA2756047C (en) 2016-04-26
IL214887A0 (en) 2011-11-30
WO2010108060A8 (en) 2011-12-29
MX2011009781A (es) 2011-10-17
EP2408299A4 (en) 2012-08-15
PL2408299T3 (pl) 2014-03-31
AU2010226476A1 (en) 2011-09-22
JP5992324B2 (ja) 2016-09-14
CN102368904A (zh) 2012-03-07
EA201171150A1 (ru) 2012-03-30
CA2756047A1 (en) 2010-09-23
KR20120014553A (ko) 2012-02-17
EP2408299A1 (en) 2012-01-25
KR101506369B1 (ko) 2015-03-30
IL214887A (en) 2015-09-24
ES2437395T3 (es) 2014-01-10
EA022569B1 (ru) 2016-01-29
CN102368904B (zh) 2014-03-26
CL2011002302A1 (es) 2012-06-22
AU2010226476B2 (en) 2013-02-07
WO2010108060A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
BRPI1014529A2 (pt) Composições de monoglicerídeo de ácido graxo
LT3037089T (lt) Eikozapentaeno rūgšties etilo esteris skirtas hipertriglicidemijai gydydti
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
BRPI1009197A2 (pt) preparação de ácido alfa-cetopimélico
EP2488022A4 (en) Compositions
SMT201600307B (it) Composizione liposomiale
UY33161A (es) Composiciones plaguicidas
FR2942627B1 (fr) Composition de graisse
EP2442645A4 (en) choline
BRPI1010709A2 (pt) composição nutricional
BRPI1013588A2 (pt) composição
LT3431076T (lt) Patobulinta lipidinė kompozicija
FR2941462B1 (fr) Composition decapante
BRPI1011650A2 (pt) composições sólidas compreendendo ácido 5-aminolevulínico
BR112013014429A2 (pt) composições de cultura iniciadora
BRPI1015474A2 (pt) composição
DOP2011000396A (es) Composiciones novedosas
HK1198515A1 (en) Fatty acid compositions
DK2234994T3 (da) Fedtsyre-butylester-blandinger
BRPI1010690A2 (pt) composições
DK2403814T3 (da) Landbrugsmæssig sammensætning
BRPI1009465A2 (pt) Formulação
EP2505644A4 (en) REGULATION COMPOSITION OF THE ATMOSPHERE
EP2404987A4 (en) PERFUME COMPOSITIONS
EP2494966A4 (en) STABLE COMPOSITION OF RASAGILINE

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]